Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:09 February,2020
Regeneron likely to make coronavirus treatments available in few months
The drugmaker on Tuesday expanded its arrangement with the U.S. Department of Health and Human Services to collaborate on developing a treatment, joining the race to develop a treatment for the virus that has killed more than 550 people.
Regeneron Pharmaceuticals Inc is ramping up efforts to develop a set of coronavirus treatments, which could be available for testing or use in some patients within a few months, the drugmaker said on Thursday....read more
PNDT Rules 2014: Geneticist may not be required to take the test
Order: The matter is listed before this Court pursuant to the request made by the learned counsel for the Appellants with reference to the Competency Based Test, 2019 scheduled to be held on 9th of this month to continue to practice which is subject matter of this writ appeal.
The learned counsel for the Appellants submits that the Appellants herein are qualified MBBS doctors and they do come within the purview of the definition of the term medical geneticist as defined under Section 2(g) of the Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 (hereinafter referred to as PCPNDT Act)....read more
Health Sutras By Dr K K Aggarwal
New or costly drugs does not always mean better.
Healthcare News Monitor
ET Healthworld Amrita Didyala
On a day when the city reported 18 new suspected cases of Novel Corona Virus (2019-nCoV), sources at Gandhi Hospital — one of the three nodal hospitals identified for tackling nCoV cases — said that they have started maintaining separate isolation wards for patients displaying ‘severe’ and ‘non-severe’ symptoms. “Two patients came to the hospital on Thursday with severe fever and cough. They have been kept in a separate isolation room than the rest,” said the source adding that authorities are making all attempts to increase the staff and capacity of isolation wards, to prepare the city for any possible outbreak. A team of five microbiologists too, sources said, are being moved from Urban Primary Health Centres (UPHCs) to the ICMR lab at Gandhi Medical College. “Since testing began in the city three days ago, 12 samples have been tested at the ICMR lab. But with the increasing load of samples of suspected nCoV cases and given the strict protocol for collection of samples as well as testing, more manpower is required. An MD microbiology is also likely to be deputed for the job,” said a highly placed source. But health officials maintain that there is no reason to panic just yet. Allaying all fears, they said all the 37 samples collected so far have tested negative for the virus. “Up to Wednesday, 37 samples had been tested, including 25 tested at the National Institute of Virology, Pune.
Sun Pharmaceuticals on Thursday posted a 26 per cent year-on-year (YoY) fall in consolidated net profit at Rs 913.52 crore compared with Rs 1,241.85 crore in the same quarter last year. Top line of the pharma major grew 4.98 per cent to Rs 8,038.65 crore for the quarter. The company announced its financial results during the market hour. Reacting on Q3 results, shares of Sun Pharma settled 1.13 per cent up at Rs 430.95. On the other hand, the benchmark BSE Sensex settled 0.40 per cent higher at 41,306. Here are the top takeaways from Sun Pharma’s third-quarter earnings: Dividend: The company’s board also announced a dividend of Rs 3 per share and fixed the record date as Tuesday, February 18. R&D: Sun Pharma made an investment of Rs 527 crore (6.6 per cent of sales) on R&D in Q3FY20 against Rs 465 crore (6 per cent of sales) in the same period last year. India Business: Sale of branded formulations in India for Q3FY20 increased 13 per cent YoY to Rs 2,517 crore. The figure accounted for 31 per cent of total consolidated sales. For the 9-month period ending December 31, sales were at Rs 7,345 crore, up by 18 per cent YoY. Taro performance: Subsidiary Taro posted 16 per cent YoY drop in Q3FY20 sales at $148 million. For the 9-month period, sales stood at $470 million, down by 4 per cent YoY. Taro’s net profit for Q3 came at $68 million. From the desk of MD: Dilip Shanghvi, Managing Director of the Company said, "Our branded business in India is doing well and has recorded double-digit growth, for Q3 as well as for the nine month period.
Abandoned infant girl found crying in drain in Nainital’s sub-zero temperature; critical
The Times of India- Prashant Jha
An infant girl was found crying in a drain in Nainital’s sub-zero temperature on Thursday morning. The girl (http://www.speakingtree.in/topics/people/girl) who was spotted by some local residents has now been referred to Haldwani hospital after receiving treatment at BD Pandey hospital. The girl is still on ventilator. Residents told TOI that they heard the girl crying early in the morning. When they came out of their homes, they saw her lying in the drain without any clothes. “Initially, we thought that maybe a child was crying in someone’s house. However, as the crying didn’t stop, we came out and found an infant lying in the drain. Nor did the girl have any clothes on or did she have a hospital tag. We immediately informed police who took her to hospital,” said Rashid, a resident. Officials of BD Pandey hospital told TOI that the girl is barely a day or two old. The doctors added that the infant had several injury marks on her body and is suffering from hypothermia. “Because she was lying in freezing temperature she is suffering from hypothermia and had several injury marks as well. We estimate her to be barely a day or two old,” said Dr Sanjeev Kharkwal, pediatrician at BD Pandey Hospital. Kharkwal added that the girl is still critical. “Though her condition is still very serious, but there are more than 50% chances of her survival,” he said. Police and the administration, meanwhile, said that they have started an investigation into the case and the parents of the child will be nabbed soon. “Police have been asked to investigate the matter promptly. Meanwhile, we have also announced that people can approach us for adopting the girl and if no one comes forward, the administration will bear the expenses of her education and marriage,” district administration officials said.
The New Indian Express
A fortnight after Chief Minister Naveen Patnaik announced a cancer hospital for Bargarh, a three-member team of doctors visited the District Headquarters Hospital (DHH) here on Thursday to identify land for the facility. According to the Directorate of Public Health, a level-3 cancer hospital will be established on the premises of the DHH that was recently inaugurated at Tukurla on the outskirts of Bargarh, with the technical support of Tata Trust through Odisha Cancer Care Foundation (OCCF). The team led by Director of Acharya Harihar Regional Cancer Centre (AHRCC)-cum-CEO of OCCF Dr L Sarangi inspected the sites on the premises of the DHH spread over 22 acres and also held discussion with Collector Jyotiranjan Pradhan and Chief District Medical Officer (CDMO) Bibhuti Bhusan Meher over the issue. Dr Sarangi said a preliminary survey was conducted to assess the type and feasibility of the cancer hospital besides identifying a site for it. A detailed project report (DPR) will be prepared on the basis of the assessment.